检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:金辉[1] 周子晔[1] 王陈翔[1] 戴歌心[1]
机构地区:[1]温州医科大学附属第一医院药学部,浙江温州325000
出 处:《中国现代应用药学》2018年第8期1245-1247,共3页Chinese Journal of Modern Applied Pharmacy
摘 要:目的分析替比夫定引起的严重不良反应,为临床合理应用提供参考。方法检索中国知网、万方和维普全文数据库,就替比夫定引起的严重不良反应进行收集、统计和分析。结果共收集替比夫定不良反应1 012例,其中严重不良反应42例,对涉及患者的一般情况、联合用药、临床表现、实验室检查、处置和转归等资料进行分析,男性41例,5例死亡,均为横纹肌溶解导致。结论临床使用替比夫定应加强监测,避免出现高死亡率的严重不良反应。OBJECTIVE To analyze the serious adverse reactions caused by telbivudine to provide a reference for clinical use of telbivudine. METHODS Search the database include CNKI, Wan Fang and VIP information, collect the serious adverse reactions caused by telbivudine, analyze the statistics. RESULTS Collected 1 012 cases of adverse reactions of telbivudine, 42 cases of them were serious. The general information, combined medication, clinical symptoms, laboratory tests results, treatments, and prognosis in patients were analyzed. There were 41 male cases, in which 5 cases of death caused by rhabdomyolysis. CONCLUSION It should be strengthened the monitoring of the clinical use of telbivudine, avoid serious adverse reactions which is high mortality.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.17.73.197